Shelby Lennon
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 1
- Peptidase Inhibition and Analysis 1
-
- Axon Guidance and Neuronal Signaling 4
-
- Peripheral Artery Disease Management 2
- Muscle and Compartmental Disorders 1
-
- Systemic Sclerosis and Related Diseases 1
- Cancer Mechanisms and Therapy 1
Shelby Lennon
10 papers receiving 441 citations
Peers
Comparison fields: 5 of 59
- Oncology 299
- Immunology 206
- Otorhinolaryngology 19
- Cancer Research 37
- Cellular and Molecular Neuroscience 37
Countries citing papers authored by Shelby Lennon
This map shows the geographic impact of Shelby Lennon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelby Lennon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelby Lennon more than expected).
Fields of papers citing papers by Shelby Lennon
This network shows the impact of papers produced by Shelby Lennon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelby Lennon. The network helps show where Shelby Lennon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shelby Lennon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 38 | |
| 2 | 2019 | 18 | |
| 3 | 2018 | 23 | |
| 4 | 2018 | 209 | |
| 5 | 2018 | 9 | |
| 6 | 2018 | 16 | |
| 7 | 2018 | 1 | |
| 8 | 2017 | 97 | |
| 9 | Patient perspectives on smoking and peripheral vascular disease. A veteran population survey. | 1990 | 12 |
| 10 | Exercise whole-body thallium scintigraphy in the diagnosis and evaluation of occlusive arterial disease in the legs. | 1990 | 23 |
About Shelby Lennon
Shelby Lennon is a scholar working on Cellular and Molecular Neuroscience, Oncology, Immunology, Pathology and Forensic Medicine and Psychiatry and Mental health, having authored 10 papers that have together received 446 indexed citations. Recurring topics across this work include Axon Guidance and Neuronal Signaling (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Peripheral Artery Disease Management (2 papers), Systemic Sclerosis and Related Diseases (1 paper), Muscle and Compartmental Disorders (1 paper), Cancer Mechanisms and Therapy (1 paper), CAR-T cell therapy research (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Oncology (299 citations), Immunology (206 citations), Otorhinolaryngology (19 citations), Cancer Research (37 citations) and Cellular and Molecular Neuroscience (37 citations). Shelby Lennon has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include David Raben, Sana D. Karam, Shilpa Bhatia, Ayman Oweida, Lynn E. Heasley, Eric T. Clambey, Andy V. Phan, Raphael A. Nemenoff, David C. Binder and Laurel B. Darragh. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Molecular Cancer Therapeutics, OncoImmunology and Thyroid.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.